Johnson & Johnson announced it will acquire Firefly Bio, Inc. for $1 billion in cash to expand its oncology pipeline. This acquisition adds Firefly Bio's proprietary Firelink™ degrader antibody conjugate (DAC) platform, designed to target KRAS-driven tumors and overcome limitations of existing treatments by selectively delivering protein degraders to cancer cells. The deal aims to strengthen Johnson & Johnson's leadership in antibody engineering for hard-to-treat solid tumors, with the transaction expected to close later this year.

Oppenheimer downgraded AT&T (T) to Perform from Outperform due to concerns regarding its long-term broadband growth and potential pressure on mobile subscriber growth from LEO satellite constellations. Analyst Timothy Horan noted that AT&T's fiber expansion plans, aiming for 60 million locations by 2030, might see lower-than-expected adoption rates. Despite these risks, AT&T has committed $19 billion to California's fiber and wireless networks, increasing its total investment in the state to $35 billion by 2030.

Susquehanna has raised its price target for CSX Corporation (NASDAQ:CSX) to $50 from $44, reiterating a Neutral rating. This decision is based on improving rail demand, with volumes tracking ahead of expectations and encouraging ISM readings showing five consecutive months of expansion, indicating higher fuel prices are not hindering industrial demand. Additionally, BofA previously maintained a Buy rating on CSX and raised its price target to $51 after the company approved a $5 billion share repurchase program.

Innodata Inc. director Don Callahan was granted 1,481 restricted stock units (RSUs) on June 4, 2026, at no cost, increasing his total holdings to 3,154 shares and RSUs. These RSUs will vest 100% on the earlier of June 4, 2027, or the company's 2027 annual meeting, and will be settled into common shares. Payment of the vested shares will be deferred until a specified future event, such as separation from service or the third anniversary of the grant date.

Century Therapeutics announced new preclinical data for CNTY-813, an iPSC-derived islet replacement therapy for Type 1 diabetes, demonstrating durable glucose control for over eight months in diabetic mice and immune evasion without immunosuppression. The therapy, engineered with Allo-Evasion™ 5.0, also showed no tumorigenesis and a scalable manufacturing process. Century plans to submit an IND for CNTY-813 in Q4 2026, with initial clinical data expected in H2 2027, aiming for a functional cure for Type 1 diabetes.

Forrester Research is undergoing a significant restructuring plan, including cost reductions and portfolio changes, after a challenging 2024. The company is sharpening its focus on core research, consulting, and events activities, emphasizing secular themes like AI and customer experience to drive subscription growth and project revenue. This strategic shift aims to improve margins and maintain relevance for investors in the technology research and advisory sector.

Autodesk, Inc. (ADSK) is a global leader in design, engineering, and entertainment software, with a market cap of $48.5 billion. Despite strong Q1 results, the stock has underperformed the Nasdaq Composite, declining 24.5% over the past 52 weeks and 24% year-to-date, compared to Nasdaq’s significant gains. Analysts, however, remain optimistic with a "Strong Buy" rating and a price target suggesting a 46.5% upside.

An entity affiliated with Dell director Egon Durban, Silver Lake Technology Investors V, L.P., sold 567 shares of Dell’s Class C Common Stock for approximately $234,978 on June 4, 2026. This transaction occurred despite Dell's stock declining recently but surging significantly over the past year, with InvestingPro data suggesting the stock is currently trading above its fair value. Dell also reported strong Q1 fiscal 2027 results and received positive outlook adjustments and price target increases from several analysts due to high demand and its positioning in the AI sector.

Egon Durban, a director at Dell Technologies and Co-CEO of Silver Lake Group, and related entities sold $519,709 worth of Dell Class C Common Stock on June 4, 2026. This sale involved 1,274 shares at prices between $401.37 and $421.08, occurring during a period when Dell's stock had declined by 8% over the past week but was still up over 256% year-over-year. The insider selling activity aligns with an InvestingPro analysis that suggests the stock might be overvalued, despite Dell's strong recent financial performance and positive adjustments to price targets by several firms due to high demand for AI servers.

General Mills has decided to sell its Haagen-Dazs ice cream shops on the Chinese mainland to an investor group including Chinese tea brand Ningji, due to intensifying competition and a need for innovation in the Chinese ice cream market. This move aligns with a broader strategy by General Mills to prioritize profitable growth. While Haagen-Dazs has seen store contraction, its new owner, Ningji, aims to leverage the brand's high-end equity to expand its product matrix and break free from low-price competition in the tea beverage market.